BioTex is organized around in the development, launch, and manufacture of medical and bio-technologies often in partnerships with entrepreneurs, start-ups, and established companies interested in bringing their own concepts to life utilizing the full spectrum of the BioTex medical device development and manufacturing capabilities. The firm is a registered FDA manufacturer and has developed products from concept to FDA 510(k) cleared medical devices and maintains a pipeline of novel medical technologies at various stages of development. BioTex, Inc. develops and manufactures laser and image-guided medical devices, undertaking R&D projects in the areas of glucose sensing, laser therapy, optical diagnostics, microbial identification, aptamers and short-interfering RNAs, and microarrays. The company also provides technologies for use in laboratory animal and animal science markets; and small animal intubation systems for academic and corporate research labs. Several of BioTex technologies have been out-licensed to achieve commercial application. The firm has aos successfuly spun off two companies: one being Visualase acquired by Medtronic in July 2014 for $104M; the other - Base Pair Biotechnologies - is an aptamer discovery and development company, spun out of Biotex, Inc. in 2012. Base Pair successfully raised $3.2M in financing in late 2017
